Global perspectives on clinical adoption of NIPT

Prenatal Diagnosis

Volumn 35, Issue 10, 2015, Pages 959-967

  Minear, Mollie A ^a   Lewis, Celine ^b   Pradhan, Subarna ^c   Chandrasekharan, Subhashini ^c  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AMNIOCENTESIS; ARGENTINA; ARTICLE; AUSTRALIA; AUSTRIA; BELGIUM; BRAZIL; BURKINA FASO; CAMEROON; CANADA; CHILE; CHORION VILLUS SAMPLING; CLINICAL PRACTICE; CLINICAL PROTOCOL; COTE D'IVOIRE; CYPRUS; CZECH REPUBLIC; DENMARK; EGYPT; FEMALE; FINLAND; FIRST TRIMESTER PREGNANCY; FRANCE; GERMANY; GREECE; HEALTH CARE COST; HONG KONG; HUMAN; HUNGARY; ICELAND; INDIA; IRAN; IRELAND; ISRAEL; ITALY; JORDAN; LEBANON; LEGAL ASPECT; LIBYAN ARAB JAMAHIRIYA; MALAYSIA; MEDICAL ETHICS; MEXICO; NETHERLANDS; NON INVASIVE PROCEDURE; NONINVASIVE PRENATAL TESTING; NORMAL HUMAN; NORWAY; PERSONAL EXPERIENCE; PORTUGAL; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HOSPITAL; QATAR; SAUDI ARABIA; SECOND TRIMESTER PREGNANCY; SENEGAL; SINGAPORE; SOUTH AFRICA; SPAIN; SWEDEN; SWITZERLAND; TREND STUDY; TUNISIA; TURKEY (REPUBLIC); UNITED ARAB EMIRATES; UNITED KINGDOM; UNITED STATES; INTERNATIONAL COOPERATION; MALE; MATERNAL SERUM SCREENING TEST; PREGNANCY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

FEMALE; HUMANS; INTERNATIONALITY; MALE; MATERNAL SERUM SCREENING TESTS; PREGNANCY; PRENATAL CARE; SURVEYS AND QUESTIONNAIRES;

EID: 84943230080     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4637     Document Type: Article

References (23)

1. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27(1):1-7.
2. van Schendel RV, Kleinveld JH, Dondorp WJ, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet 2014;22(12):1345-50.
3. Lewis C, Silcock C, Chitty LS. Non-invasive prenatal testing for Down's syndrome: pregnant women's views and likely uptake. Public Health Genomics 2013;16(5):223-32.
4. Yi H, Hallowell N, Griffiths S, et al. Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong. PLoS One 2013;8(11):e81794.
5. Skirton H, Patch C. Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review. Prenat Diagn 2013;33(6):532-41.
6. Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015;45(3):249-66.
7. Royal College of Obstetricians & Gynaecologists. Non-invasive prenatal testing for chromosomal abnormality using maternal plasma DNA. RCOG Scientific Impact Paper No. 15. 2014.
8. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15(5):395-8.
9. Alexander E, Kelly S, Kerzin-Storrar L. Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives. J Genet Counsel 2014; 1-12.
10. Tischler R, Hudgins L, Blumenfeld YJ, et al. Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat Diagn 2011;31(13):1292-9.
11. Yotsumoto J, Sekizawa A, Koide K, et al. Attitudes toward non-invasive prenatal diagnosis among pregnant women and health professionals in Japan. Prenat Diagn 2012;32(7):674-9.
12. Chandrasekharan S, Minear MA, Hung A, et al. Noninvasive prenatal testing goes global. Sci Transl Med 2014;6(231):231fs15.
13. Larion S, Warsof SL, Romary L, et al. Uptake of noninvasive prenatal testing at a large academic referral center. Am J Obstet Gynecol 2014; 211(6):651.e1-7.
14. Chan YM, Leung WC, Chan WP, et al. Women's uptake of non-invasive DNA testing following a high-risk screening test for trisomy 21 within a publicly funded healthcare system: findings from a retrospective review. Prenat Diagn 2014 [epub ahead of print].
15. Chetty S, Garabedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013;33(6):542-6.
16. Hill M, Wright D, Daley R, et al. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol. BMC Pregnancy Childbirth 2014;14:229.
17. EMGO Institute for Health and Care Research. Non invasive prenatal test (NIPT) now allowed in The Netherlands within TRIDENT study 2014 [WWW document]. URL http://www.emgo.nl/news-and-events/news/486/non-invasive-prenatal-test-nipt-now-allowed-in-the-netherlands-within-trident-study/ [accessed on 20 March 2015].
18. PEGASUS. About the PEGASUS project 2015 [WWW document]. URL http://pegasus-pegase.ca/pegasus/ [accessed on 20 March 2015].
19. Benn P, Borrell A, Chiu R, et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis [WWW document]. URL http://www.ispdhome.org/public/news/2015/PositionStatementFinal04082015.pdf [accessed on 11 May 2015].
20. Ariosa Diagnostics, Inc. Microarray technology proves superior to sequencing for non-invasive prenatal testing [WWW document]. URL http://www.ariosadx.com/news-events/microarray-technology-proves-superior-nipt/ [accessed on 20 March 2015].
21. World Bank. Country and lending groups [WWW document]. URL http://data.worldbank.org/about/country-and-lending-groups [accessed on 20 March 2015].
22. Clausen FB. Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care. Prenat Diagn 2014;34(5):409-15.
23. Chitty LS, Finning K, Wade A, et al. Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study. BMJ 2014;349:g5243.